RightFit
Not yet recruitingNot applicable

A New Way to Share Radiation Therapy Plans Between Doctors, CORRECT Trial

Collaborative Oncology Between Radiologists and Radiation Oncologists for the Evaluation of Contoured Targets (CORRECT)

Who can join

As published by the study on ClinicalTrials.gov. "Not stated" means the study hasn't said — ask the study team.

Age
18 Years and older
Sex
All sexes
Healthy volunteers
Accepted
Compensation
Not stated

Other requirements are listed under Eligibility below. Only the study team can confirm whether you can join.

What to expect

No one can promise a trial will help you personally — that is what the research is trying to find out.

What participation involves

  • Time periods mentioned: 12 months
  • Procedures mentioned: CT scans, Interviews

Only what the study's summary and detailed description on ClinicalTrials.gov say. Time periods may describe the whole study or a part of it — ask the study team what applies to you.

Show the study's own words
  • "Computed tomography (CT) images are then fused with RT targets and pushed to a pre-designated Picture Archiving and Communications System (PACS) software folder accessible by the radiology department."
  • "To identify facilitators and barriers to radiation oncology-radiology standard of care collaboration, CORRECT workflow implementation, and participation in the future trial using a qualitative interview."
  • "ROs and radiologists then use the CORRECT workflow with patient cases for 12 months"
Compensation
Not stated
  • Study-related exams and procedures are typically provided at no cost. This is how many trials work in general — confirm the details for this study with the study team.
  • Participants are monitored closely by the research team throughout the study.
  • Some participants may receive access to an investigational treatment, which is still being studied.
  • Your participation helps researchers learn whether this approach could help future patients.

About this study

In plain language

This study tests CORRECT, a new way for radiation doctors and doctors who read scans to share and review radiation treatment plans. It includes medical practices, doctors, and adults with lung or head and neck cancer who plan to get radiation treatment aimed at curing their cancer.

This clinical trial tests a new way to share radiation therapy plans using the Collaborative Oncology between Radiologists and Radiation oncologists for the Evaluation of Contoured Targets (CORRECT) workflow to improve communication and collaboration between radiation oncologists (ROs) and radiologists when determining cancer targets for radiation treatment. Systemic barriers limit critical communication between radiation oncologists and radiologists and can lead to both under and overdosing of radiation therapy (RT) tumor targets and failures to properly interpret post-treatment imaging. The limited formal diagnostic radiology training of many providers can make differentiating normal from disease imaging findings during target determination difficult, especially in complex disease sites like the lung, head, and neck. Inaccurate target determination may result in cancer return, excess toxicity, or both. Likewise, radiologists who cannot access prior RT plans may mistake expected RT changes for recurrent cancer or overlook true progression. The CORRECT workflow was developed by ROs and radiologists to address RO-radiology communication barriers by facilitating sharing of comprehensive RT target contours during RT planning. The CORRECT workflow begins with the normal process of RO target contouring. Computed tomography (CT) images are then fused with RT targets and pushed to a pre-designated Picture Archiving and Communications System (PACS) software folder accessible by the radiology department. The radiologist can then review the fused images at their chosen time and annotate images to indicate potential deviations (e.g., not avoiding normal tissue or not including all tumor). The RO reviews the annotated images and decides if any changes to treatment targets are needed for the final treatment plan. Through this independent, asynchronous review of high-quality images, CORRECT overcomes many of the limitations of existing communication methods between RO-radiologist, fostering a more collaborative, efficient, and precise approach to cancer treatment planning.

Compensation is read from the study's own description and may be missing — always confirm with the study team.

Eligibility

Who can join

  • Patients must be age 18 or older and have lung or head and neck cancer at any stage.
  • Patients must plan to get radiation aimed at curing their cancer, with or without other treatments. Their radiation doctor must record this goal in their health record.
  • Patients must expect to be treated by a radiation doctor who is taking part in this study.
  • Practices must give radiation treatment to at least 3 patients with lung or head and neck cancer each month.
  • Practices must have at least one radiation doctor and one doctor who reads scans willing to join. The team must use PACS, software for storing and sharing medical images.
  • Both types of doctors must have worked without a supervising trainer for at least 6 months. Radiation doctors must treat lung or head and neck cancer with radiation aimed at a cure.
  • Both types of doctors must complete 15 minutes of online CORRECT training and agree to a 30-minute interview if chosen at the end of the study.
  • Doctors who read scans must agree to review radiation targets before treatment during the study, which lasts about 12 months.

Who can't join

  • Community practices cannot join if they are in another National Cancer Institute NCORP cancer care delivery study supported by a U34 grant funded in fiscal year 2025 or later. The WF-2301CD CONNECT study is an exception.
  • Doctors cannot join if they plan to leave the practice within 12 months or work there only as temporary staff.
  • Patients cannot join if they cannot understand English or Spanish.
  • Patients cannot join if they have early cancer in the vocal cord area of the voice box and plan to receive radiation alone as their main treatment.

Simplified for readability. The official criteria below are what the study team uses.

Official eligibility criteria

Inclusion Criteria: * PRACTICE: Must provide radiation therapy for ≥ 3 patients per month with lung cancer or head \& neck cancer * PRACTICE: At least one radiation oncologist and one radiologist (in house, contracted, etc.) at the practice willing to participate, but may have multiple participants at the practice * PRACTICE: Radiation oncologist/radiologist team must use Picture Archiving and Communication System (PACS) software at this practice * RADIATION ONCOLOGIST (NON-PATIENT): Must have been in independent practice (i.e., performing duties without preceptor oversight) for a minimum of six months * RADIATION ONCOLOGIST (NON-PATIENT): Must treat lung and/or head \& neck cancer patients with curative intent radiation therapy * RADIATION ONCOLOGIST (NON-PATIENT): Willing and able to participate in 15 minutes of mandatory virtual CORRECT training * RADIATION ONCOLOGIST (NON-PATIENT): Willing to participate in a 30-minute interview, if selected at the end of the study * RADIOLOGIST (NON-PATIENT): Must have been in independent practice (i.e., performing duties without preceptor oversight) for a minimum of six months * RADIOLOGIST (NON-PATIENT): Agree to review pre-treatment radiation therapy targets during the course of the study duration (approximately 12 months). Willing and able to participate in 15 minutes of mandatory virtual CORRECT training * RADIOLOGIST (NON-PATIENT): Willing to participate in a 30-minute interview, if selected at the end of the study * PATIENT: Must have any stage of clinically diagnosed lung or head \& neck (HN) cancer * PATIENT: Planned treatment with curative intent definitive RT (with or without other treatments). Curative intent RT must be documented in the electronic medical record (EMR) by the treating radiation oncologist * PATIENT: Must be expected to be treated by a radiation oncologist participating in this study * PATIENT: Must be 18 years or older Exclusion Criteria: * PRACTICE: Participation by the Community Site or Minority/Underserved Community Site in another National Cancer Institute (NCI) Community Oncology Research Program (NCORP) Cancer Care Delivery Research (CCDR) U34-supported protocol funded in NCI fiscal year 2025 or later. (Note: WF- 2301CD CONNECT is exempt from this policy, as it was funded prior to NCI fiscal year 2025.) * RADIATION ONCOLOGIST (NON-PATIENT): Planning to leave their position at this practice within the next 12 months * RADIATION ONCOLOGIST (NON-PATIENT): Providing service on a temporary basis (i.e., locum tenens providers) * RADIOLOGIST (NON-PATIENT): Planning to leave their position at this practice within the next 12 months * RADIOLOGIST (NON-PATIENT): Providing service on a temporary basis (i.e., locum tenens providers) * PATIENT: Unable to understand English or Spanish * PATIENT: Early glottic larynx cancer planned for definitive RT alone

Study sites (1)

NC